Fig. 2From: Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION studyKaplan–Meier cumulative event curves for primary and secondary outcomes. The Kaplan–Meier curves display the time to event for the all-cause mortality (a) and cardiovascular mortality (b), nonfatal myocardial infarction (c), stroke (d), congestive heart failure (e) and a major coronary heart disease event (f) during trial period, post-trial and the entire study period. The numbers of individuals at risk are shown for each time pointBack to article page